FLUSHPIRILEN (Fluspirilenum). 8-[4, 4 - Bis (para-ftorfenil) - butyl] - 1-phenyl-1, 3, 8-triazaspiro- [4, 5] 4-dekan- it.

     Synonyms: Fluspirilen, Fluspirilene, Redeptin, Spirodiflamine, IMAP (intramuskulyarny antipsihotik).

     Microcrystalline powder, insoluble in water. Issued in the form of suspensions in water containing 1 ml of 0,002 grams (2 mg) drugs.

     Flushpirilen-derived difenilbutilpiperidina. Is an active adjunct tool provider antipsihotichesky pronounced effect. On the spectrum of pharmacological close to galoperidolu. Effective with the hallucinations, crazy, inexplicable. Comfort also emotional and psychomotor agitation.

     The main feature is its flushpirilena prolonged effect. After a single vnutrimyshechnogo as suspension continues in effect during 1 week.

     The product is used primarily to support treatment of patients with chronic mental illness after treatment in a hospital. Suitable for use in outpatient practice because of the lack of express gipnosedativnogo action. Facilitate reintegration and rehabilitation patients. You can apply flushpirilen in hospital with schizophrenia and other mental illnesses, accompanied by hallucinations, crazy, psychomotor stimulation. Flushpirilen can be combined with conventional (neprolongirovannymi) neyrolepticheskimi drugs have psihosedativnoe effect.

     Enter suspension flushpirilena intramuscularly once a week. In-patient entering first 4-6 mg (2 to 3 ml), and if necessary to increase the dose of 8 to 10 mg (4 - 5 ml). Upon reaching the optimal dose effect gradually decrease to maintain a weekly dose of 2 to 6 mg (1 - 3 ml).

     With prolonged treatment can be repeated every 3 to 4 weeks to one week break.

     In outpatients impose on 2 -6 mg (-3 1 ml) once a week.

     Using the drug could develop extrapyramidal disorders; For prevention to a day of flushpirilena and in the next two days to apply antiparkinsonicheskie funds. With long-term care flushpirilenom can reduce body weight, general weakness, deterioration of sleep, depression. On the first day after the injections might feel nausea and fatigue.

     The product contraindications to ekstrapiramidnyh violations, depression, motor disorders.

     Do not appoint flushpirilen women in the first three months beremonnosti.

     Form release: in 2 ml ampoule containing 1 ml of 0,002 grams (2 mg) flushpirilena (4 mg in 1 ampoule). Before injection vials should seriously shake (for homogenization mist).

Materials allowed to copy only with the active hyperlink to the handbook of medicines